Filing Details

Accession Number:
0001062993-23-003511
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-02-14 17:47:50
Reporting Period:
2023-01-04
Accepted Time:
2023-02-14 17:47:50
Original Submission Date:
2023-01-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1907685 Comera Life Sciences Holdings Inc. CMRA Pharmaceutical Preparations (2834) 874706968
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1926230 James Sherblom C/O Comera Life Sciences Holdings, Inc.
12 Gill Street, Suite 4650
Woburn MA 01801
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-04 81,081 $1.23 452,244 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2023-01-04 81,081 $0.25 162,162 $1.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
81,081 2023-01-04 2028-01-04 No 4 P Direct
Footnotes
  1. This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from "A" to "P" and (ii) correct a typographical error in the power-of-attorney of the reporting person.
  2. The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 81,081 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules.
  3. The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.